BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Caccamo G, Saffioti F, Raimondo G. Hepatitis B virus and hepatitis C virus dual infection. World J Gastroenterol 2014; 20(40): 14559-14567 [PMID: 25356020 DOI: 10.3748/wjg.v20.i40.14559]
URL: https://www.wjgnet.com/1948-5182/full/v20/i40/14559.htm
Number Citing Articles
1
C. M. Preda, C. P. Popescu, C. Baicus, I. Constantinescu, A. Oproiu, T. Voiosu, M. Diculescu, L. Negreanu, L. Gheorghe, I. Sporea, A. Trifan, E. Ceausu, D. Proca, M. Manuc. Risk of hepatitis B virus reactivation in hepatitis B virus + hepatitis C virus-co-infected patients with compensated liver cirrhosis treated with ombitasvir, paritaprevir/r + dasabuvir + ribavirinJournal of Viral Hepatitis 2018; 25(7): 834 doi: 10.1111/jvh.12872
2
Harjot K. Bedi, Daljeet Chahal, Christopher F. Lowe, Gordon Ritchie, Trana Hussaini, Vladimir Marquez, Eric M. Yoshida. Occult Hepatitis B Reactivation after Liver Transplant: The Role of a Novel Mutation in the Surface AntigenJournal of Clinical and Translational Hepatology 2020; 0(000): 1 doi: 10.14218/JCTH.2020.00090
3
Evangelos Stournaras, Georgios Neokosmidis, Dimitrios Stogiannou, Andreas Protopapas, Konstantinos Tziomalos. Effects of antiviral treatment on the risk of hepatocellular cancer in patients with chronic viral hepatitisEuropean Journal of Gastroenterology & Hepatology 2018; 30(11): 1277 doi: 10.1097/MEG.0000000000001254
4
Vincent Soriano, Pablo Labarga, Carmen de Mendoza, José V Fernández-Montero, Isabella Esposito, Laura Benítez-Gutiérrez, José M Peña, Pablo Barreiro. New hepatitis C therapies for special patient populationsExpert Opinion on Pharmacotherapy 2016; 17(2): 217 doi: 10.1517/14656566.2016.1112790
5
Fei Chen, Jian Zhang, Fengfan Guo, Bo Wen, Shan Luo, Dongping Yuan, Yingbiao Lin, Wensheng Ou, Ping Tang, Guozhi Dai, Fangfang Li, Wenpei Liu, Xiaowang Qu. Hepatitis B, C, and D virus infection showing distinct patterns between injection drug users and the general populationJournal of Gastroenterology and Hepatology 2017; 32(2): 515 doi: 10.1111/jgh.13460
6
Ruchi Sogarwal, Varada Madge, Pratyush Bishi, Apam Woleng, Rishi Garg. Predisposing, enabling, and need factors associated with utilization of HCV testing services among PWID in two settings in IndiaHepatology, Medicine and Policy 2016; 1(1) doi: 10.1186/s41124-016-0010-z
7
Fei Chen, Jian Zhang, Bo Wen, Shan Luo, Yingbiao Lin, Wensheng Ou, Fengfan Guo, Ping Tang, Wenpei Liu, Xiaowang Qu. HBV/HCV dual infection impacts viral load, antibody response, and cytokine expression differently from HBV or HCV single infectionScientific Reports 2016; 6(1) doi: 10.1038/srep39409
8
Jamil A. Al-Mughales. Co-infection assessment in HBV, HCV, and HIV patients in Western Saudi ArabiaJournal of Medical Virology 2016; 88(9): 1545 doi: 10.1002/jmv.24503
9
Jason Grebely, Geert Robaeys, Philip Bruggmann, Alessio Aghemo, Markus Backmund, Julie Bruneau, Jude Byrne, Olav Dalgard, Jordan J. Feld, Margaret Hellard, Matthew Hickman, Achim Kautz, Alain Litwin, Andrew R. Lloyd, Stefan Mauss, Maria Prins, Tracy Swan, Martin Schaefer, Lynn E. Taylor, Gregory J. Dore. Recomendaciones para el manejo de la infección por el virus de la hepatitis C entre usuarios de drogas por vía parenteralInternational Journal of Drug Policy 2015; : 101671 doi: 10.1016/j.drugpo.2015.11.011
10
Marc G. Ghany, T. Jake Liang. Hepatitis C Virus II2016; : 3 doi: 10.1007/978-4-431-56101-9_1
11
Jiaye Liu, Hui Wu, Hui Chen. Immune response to hepatitis B vaccine in patients with chronic hepatitis C infection: A systematic review and meta-analysisHepatology Research 2018; 48(2): 119 doi: 10.1111/hepr.13008
12
Astrid Marot, Aïmen Belaid, Hans Orlent, Thomas Sersté, Peter Michielsen, Isabelle Colle, Wim Laleman, Chantal de Galocsy, Hendrik Reynaert, François D’Heygere, Christophe Moreno, Christopher Doerig, Jean Henrion, Pierre Deltenre. Characteristics of patients with hepatitis B virus and hepatitis C virus dual infection in a Western European country: Comparison with monoinfected patientsClinics and Research in Hepatology and Gastroenterology 2017; 41(6): 656 doi: 10.1016/j.clinre.2017.05.003
13
D. Salmon, M. U. Mondelli, M. Maticic, J. E. Arends. The benefits of hepatitis C virus cure: Every rose has thornsJournal of Viral Hepatitis 2018; 25(4): 320 doi: 10.1111/jvh.12823
14
Prabha Desikan, Zeba Khan. Prevalence of Hepatitis B and Hepatitis C Virus Co-infection in India: A Systematic Review and Meta-analysisIndian Journal of Medical Microbiology 2017; 35(3): 332 doi: 10.4103/ijmm.IJMM_17_257
15
Anand V Kulkarni, Nageshwar Reddy Duvvuru. Management of hepatitis B and C in special populationWorld Journal of Gastroenterology 2021; 27(40): 6861-6873 doi: 10.3748/wjg.v27.i40.6861
16
Yung-Rung Lai, Ya-Lan Chang, Chiu-Hsiang Lee, Tung-Han Tsai, Kuang-Hua Huang, Chien-Ying Lee. Risk of Non-Hodgkin Lymphoma among Patients with Hepatitis B Virus and Hepatitis C Virus in Taiwan: A Nationwide Cohort StudyCancers 2022; 14(3): 583 doi: 10.3390/cancers14030583
17
Jennifer Mbamalu Chinenye, Mercy Ekejindu Ifeoma, Bessie Enweani-Nwokelo Ifeoma, Ikechukwu Okeke Obiefuna, Amaechi Ofodile Chukwudi, Okorafor Kalu Stephen. Frequency of hepatitis C and D virus among chronic hepatitis B virus carriers in a Nigerian tertiary hospitalJournal of Public Health and Epidemiology 2022; 14(1): 10 doi: 10.5897/JPHE2021.1367
18
MURAT SAYAN, AYSE ARIKAN, TAMER SANLIDAG. Comparison of Performance Characteristics of DxN VERIS System versus Qiagen PCR for HBV Genotype D and HCV Genotype 1b QuantificationPolish Journal of Microbiology 2019; 68(1): 139 doi: 10.21307/pjm-2019-008
19
Anahita Rahimkhani, Setareh Haghighat, Hassan Noorbazargan, Mehdi Mahdavi. Improvement of hepatitis B vaccine to induce IFN-γ cytokine response: A new formulationMicrobial Pathogenesis 2021; 160: 105184 doi: 10.1016/j.micpath.2021.105184
20
Jiaye Liu, Shaohui Qiu, Jingjing Lu, Bingyu Yan, Yi Feng, Li Li, Guomin Zhang, Fuzhen Wang, Peng He, Xin Fang, Zhongyu Hu, Xiaofeng Liang, Aiqiang Xu, Li Zhang. Robust Antibody and Cytokine Response to Hepatitis B Vaccine Among Not-in-Treatment Patients With Chronic Hepatitis C: An Open-Label Control Study in ChinaThe Journal of Infectious Diseases 2017; 216(3): 327 doi: 10.1093/infdis/jix295
21
Muhammad Younas Khan Barozai, Muhammad Din. Initial screening of plant most conserved MicroRNAs targeting infectious viruses: HBV and HCV2017 14th International Bhurban Conference on Applied Sciences and Technology (IBCAST) 2017; : 192 doi: 10.1109/IBCAST.2017.7868055
22
Yin Liu, Lan-Wei Guo, Hui-Fang Xu, Rui-Hua Kang, Li-Yang Zheng, Lu-Yao Zhang, Qiong Chen, Xi-Bin Sun, Shao-Kai Zhang, You-Lin Qiao. Risk of Liver Cirrhosis in HBV/HCV-Infected Individuals with First-Degree Relatives Who Have Liver Cancer: Development and Validation of a Simple ModelCancer Prevention Research 2022; 15(2): 111 doi: 10.1158/1940-6207.CAPR-21-0220
23
L. Reinhardt, H. Eiffert, G. Wulf, P. Ströbel, S. C. B. Bremer, A. Amanzada, V. Ellenrieder, A. Neesse. Spontane Remission einer HCV-Infektion nach autologer Stammzelltransplantation bei einem 58-jährigen PatientenDer Internist 2017; 58(6): 621 doi: 10.1007/s00108-017-0206-3
24
Shaoxia Xu, Qiaofeng Wang, Weihong Zhang, Zhifeng Qiu, Jingtao Cui, Wenjuan Yan, Anping Ni, Julian W. Tang. Seroprevalence of the Hepatitis B, Hepatitis C, and Human Immunodeficiency Viruses and Treponema pallidum at the Beijing General Hospital from 2010 to 2014: A Cross-Sectional StudyPLOS ONE 2015; 10(10): e0140854 doi: 10.1371/journal.pone.0140854
25
Jacinta A. Holmes, Ming-Lung Yu, Raymond T. Chung. Hepatitis B reactivation during or after direct acting antiviral therapy – implication for susceptible individualsExpert Opinion on Drug Safety 2017; 16(6): 651 doi: 10.1080/14740338.2017.1325869
26
Shilpa Lingala, Marc G. Ghany. Natural History of Hepatitis CGastroenterology Clinics of North America 2015; 44(4): 717 doi: 10.1016/j.gtc.2015.07.003
27
Michelle Spaan, Matthew Bruce, Kosh Agarwal, Ivana Carey. The Role of Anti-HBs in Hepatitis B Reactivation during Direct-Acting Antiviral Therapy for Chronic Hepatitis CAntiviral Therapy 2018; 23(6): 539 doi: 10.3851/IMP3259
28
Luca Foroghi Biland, Ludovica Ferrari, Vincenzo Malagnino, Elisabetta Teti, Carlotta Cerva, Adele Gentile, Marianna Aragri, Romina Salpini, Valentina Svicher, Massimo Andreoni, Loredana Sarmati. Hepatitis B virus reactivation sustained by a hepatitis B virus surface antigen immune-escape mutant isolate in a patient who was hepatitis B core antibody positive during treatment with sofosbuvir and velpatasvir for hepatitis C virus infection: a case reportJournal of Medical Case Reports 2019; 13(1) doi: 10.1186/s13256-019-2232-3
29
Zhi-Wei Chen, Zhao Li, Qiao-He Wang, Xiao-Ling Wu, Hu Li, Hong Ren, Peng Hu. Large Disparity between Prevalence and Treatment Rates for Hepatitis C in Western ChinaJournal of Clinical and Translational Hepatology 2018; 6(X): 1 doi: 10.14218/JCTH.2018.00027
30
Cristina Musolino, Irene Cacciola, Gianluca Tripodi, Daniele Lombardo, Giuseppina Raffa, Angela Alibrandi, Giovanni Squadrito, Giovanni Raimondo, Teresa Pollicino. Behaviour of Occult HBV Infection in HCV-Infected Patients under Treatment with Direct-Acting AntiviralsAntiviral Therapy 2019; 24(3): 187 doi: 10.3851/IMP3288
31
Shuling Wu, Wei Yi, Yuanjiao Gao, Wen Deng, Xiaoyue Bi, Yanjie Lin, Liu Yang, Yao Lu, Ruyu Liu, Min Chang, Ge Shen, Leiping Hu, Lu Zhang, Minghui Li, Yao Xie. Immune Mechanisms Underlying Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B Patients With Viral CoinfectionFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.893512
32
Vincent Thibault. Hepatitis B virus reactivation after direct-acting antivirals for chronic hepatitis C infectionThe Lancet Gastroenterology & Hepatology 2018; 3(3): 145 doi: 10.1016/S2468-1253(18)30004-9
33
Pascal Mutz, Philippe Metz, Florian A. Lempp, Silke Bender, Bingqian Qu, Katrin Schöneweis, Stefan Seitz, Thomas Tu, Agnese Restuccia, Jamie Frankish, Christopher Dächert, Benjamin Schusser, Ronald Koschny, Georgios Polychronidis, Peter Schemmer, Katrin Hoffmann, Thomas F. Baumert, Marco Binder, Stephan Urban, Ralf Bartenschlager. HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of InterferonGastroenterology 2018; 154(6): 1791 doi: 10.1053/j.gastro.2018.01.044
34
Somayeh Shokri, Shahab Mahmoudvand, Reza Taherkhani, Fatemeh Farshadpour, Farid Azizi Jalalian. Complexity on modulation of NF‐κB pathways by hepatitis B and C: A double‐edged sword in hepatocarcinogenesisJournal of Cellular Physiology 2019; 234(9): 14734 doi: 10.1002/jcp.28249
35
Jason Grebely, Geert Robaeys, Philip Bruggmann, Alessio Aghemo, Markus Backmund, Julie Bruneau, Jude Byrne, Olav Dalgard, Jordan J. Feld, Margaret Hellard, Matthew Hickman, Achim Kautz, Alain Litwin, Andrew R. Lloyd, Stefan Mauss, Maria Prins, Tracy Swan, Martin Schaefer, Lynn E. Taylor, Gregory J. Dore. Empfehlungen zur Hepatitis Versorgung bei DrogenkonsumierendenInternational Journal of Drug Policy 2015; : 101670 doi: 10.1016/j.drugpo.2015.11.010
36
Ge Yu, Xiumei Chi, Ruihong Wu, Xiaomei Wang, Xiuzhu Gao, Fei Kong, Xiangwei Feng, Yuanda Gao, Xinxing Huang, Jinglan Jin, Yue Qi, Zhengkun Tu, Bing Sun, Jin Zhong, Yu Pan, Junqi Niu, Yury E Khudyakov. Replication Inhibition of Hepatitis B Virus and Hepatitis C Virus in Co-Infected Patients in Chinese PopulationPLOS ONE 2015; 10(9): e0139015 doi: 10.1371/journal.pone.0139015
37
Lauren Myers, Arnab Mitra, Joseph Ahn. Addressing Hepatitis B in the Context of Hepatitis CCurrent Hepatology Reports 2021; 20(4): 175 doi: 10.1007/s11901-021-00578-6
38
Elisabetta Loggi, Stefano Gitto, Silvia Galli, Mario Minichiello, Fabio Conti, Elena Grandini, Alessandra Scuteri, Giovanni Vitale, Roberto Di Donato, Carmela Cursaro, Giuliano Furlini, Pietro Andreone. Hepatitis B virus reactivation among hepatitis C patients treated with direct-acting antiviral therapies in routine clinical practiceJournal of Clinical Virology 2017; 93: 66 doi: 10.1016/j.jcv.2017.05.021
39
Marlone Cunha-Silva, Fábio R.T. Marinho, Paulo F. Oliveira, Tirzah M. Lopes, Tiago Sevá-Pereira, Sonia L.S. Lorena, Jazon R.S. Almeida. Retrospective analysis of hepatitis B virus chronic infection in 247 patients: clinical stages, response to treatment and poor prognostic factorsThe Brazilian Journal of Infectious Diseases 2017; 21(4): 441 doi: 10.1016/j.bjid.2017.03.019
40
Aida Lydia, Anindia Larasati, Rino Alvani Gani, Ikhwan Rinaldi. Liver fibrosis of hepatitis C virus infection in routine hemodialysis patients in IndonesiaMedical Journal of Indonesia 2019; 28(4): 375 doi: 10.13181/mji.v28i4.3776
41
Xiao-Xiao Wang, Xiao-Ben Pan, Jin-Chao Han, Xu Cong, Qian Jin, Xiang-Sha Kong, Lai Wei, Bo Feng. HBsAg stimulates NKG2D receptor expression on natural killer cells and inhibits hepatitis C virus replicationHepatobiliary & Pancreatic Diseases International 2018; 17(3): 233 doi: 10.1016/j.hbpd.2018.03.010
42
Jason Grebely, Geert Robaeys, Philip Bruggmann, Alessio Aghemo, Markus Backmund, Julie Bruneau, Jude Byrne, Olav Dalgard, Jordan J. Feld, Margaret Hellard, Matthew Hickman, Achim Kautz, Alain Litwin, Andrew R. Lloyd, Stefan Mauss, Maria Prins, Tracy Swan, Martin Schaefer, Lynn E. Taylor, Gregory J. Dore. Recommendations for the management of hepatitis C virus infection among people who inject drugsInternational Journal of Drug Policy 2015; 26(10): 1028 doi: 10.1016/j.drugpo.2015.07.005
43
Carla S. Coffin, Scott K. Fung, Fernando Alvarez, Curtis L. Cooper, Karen E. Doucette, Claire Fournier, Erin Kelly, Hin Hin Ko, Mang M Ma, Steven R Martin, Carla Osiowy, Alnoor Ramji, Edward Tam, Jean Pierre Villeneuve. Management of Hepatitis B Virus Infection: 2018 Guidelines from the Canadian Association for the Study of Liver Disease and Association of Medical Microbiology and Infectious Disease CanadaCanadian Liver Journal 2018; 1(4): 156 doi: 10.3138/canlivj.2018-0008
44
Elisabetta Degasperi, Massimo Colombo. Hepatitis C: Epidemiology, Prevention and Elimination2021; : 151 doi: 10.1007/978-3-030-64649-3_7
45
Stefano GITTO, Carmela CURSARO, Alessandra BARTOLI, Marzia MARGOTTI, Pietro ANDREONE. Hepatitis C: clinical management and debated issuesMinerva Medica 2021; 112(2) doi: 10.23736/S0026-4806.20.07208-0
46
Rachael Jacob, Mark Danta. Pharmacotherapeutic strategies for hepatitis B and hepatitis C coinfectionExpert Opinion on Pharmacotherapy 2022; 23(4): 465 doi: 10.1080/14656566.2021.2019708
47
Elaheh Gholami Parizad, Eskandar Gholami Parizad, Afra Khosravi, Mansour Amraei, Azar Valizadeh, Abdoullah Davoudian. Comparing HBV Viral Load in Serum, Cerumen, and Saliva and Correlation With HBeAg Serum Status in Patients With Chronic Hepatitis B InfectionHepatitis Monthly 2016; 16(5) doi: 10.5812/hepatmon.30385
48
Dorota Zarębska-Michaluk, Robert Flisiak, Marta Flisiak-Jackiewicz. Management of hepatitis B and hepatitis C coinfection: an expert reviewExpert Review of Anti-infective Therapy 2020; 18(10): 1033 doi: 10.1080/14787210.2020.1776112
49
INASL Position Statements on Prevention, Diagnosis and Management of Hepatitis B Virus Infection in India: The Andaman StatementsJournal of Clinical and Experimental Hepatology 2018; 8(1): 58 doi: 10.1016/j.jceh.2017.12.001
50
Zebin Zhu, Shanzhou Huang, Yixi Zhang, Chengjun Sun, Yunhua Tang, Qiang Zhao, Qi Zhou, Weiqiang Ju, Xiaoshun He. Bioinformatics analysis on multiple Gene Expression Omnibus datasets of the hepatitis B virus infection and its response to the interferon-alpha therapyBMC Infectious Diseases 2020; 20(1) doi: 10.1186/s12879-019-4720-x
51
Jerzy Jaroszewicz, Małgorzata Pawłowska, Krzysztof Simon, Dorota Zarębska-Michaluk, Beata Lorenc, Jakub Klapaczyński, Magdalena Tudrujek-Zdunek, Marek Sitko, Włodzimierz Mazur, Ewa Janczewska, Katarzyna Paluch, Dorota Dybowska, Iwona Buczyńska, Agnieszka Czauż-Andrzejuk, Hanna Berak, Rafał Krygier, Maciej Piasecki, Beata Dobracka, Jolanta Citko, Anna Piekarska, Łukasz Socha, Zbigniew Deroń, Olga Tronina, Łukasz Laurans, Jolanta Białkowska, Krzysztof Tomasiewicz, Waldemar Halota, Robert Flisiak. Low risk of HBV reactivation in a large European cohort of HCV/HBV coinfected patients treated with DAAExpert Review of Anti-infective Therapy 2020; 18(10): 1045 doi: 10.1080/14787210.2020.1782189
52
Siyue Zhu, Kibrom Mehari Kahsay, Li Gui. Knowledge, Attitudes and Practices related to standard precautions among nurses: A comparative studyJournal of Clinical Nursing 2019; 28(19-20): 3538 doi: 10.1111/jocn.14945
53
Marwan SM Al-Nimer. Is COVID-19-induced liver injury different from other RNA viruses?‎World Journal of Meta-Analysis 2021; 9(2): 108-127 doi: 10.13105/wjma.v9.i2.108
54
Amrita Gaurav, Dhriti Kapur, Neha Verma, Anupama Bahadur, Kavita Khoiwal, Anchal Agarwal, Om Kumari, Jaya Chaturwedi. Do Blood-Borne Viruses Affect the Progression of Labor: A Hospital-Based Pilot StudyCureus 2021;  doi: 10.7759/cureus.15631
55
D. V. Tserashkou, V. M. Mitsura, E. V. Voropaev, O. V. Osipkina. VIRAL COINFECTIONS IN PATIENTS WITH CHRONIC HEPATITIS B: THEIR PREVALENCE AND CLINICAL SIGNIFICANCEHepatology and Gastroenterology 2020; 4(2): 171 doi: 10.25298/2616-5546-2020-4-2-171-176
56
Amin R. Soliman, Rabab M. Ahmed, Mahmoud Soliman, Ahmed Abdallah, Bahaa Zayed. The effect of co-infection with hepatitis B and hepatitis C viruses on the prevalence of proteinuria and loss of renal function: a single-center experienceThe Egyptian Journal of Internal Medicine 2018; 30(4): 271 doi: 10.4103/ejim.ejim_51_18
57
Jason Grebely, Geert Robaeys, Philip Bruggmann, Alessio Aghemo, Markus Backmund, Julie Bruneau, Jude Byrne, Olav Dalgard, Jordan J. Feld, Margaret Hellard, Matthew Hickman, Achim Kautz, Alain Litwin, Andrew R. Lloyd, Stefan Mauss, Maria Prins, Tracy Swan, Martin Schaefer, Lynn E. Taylor, Gregory J. Dore. Recommandations pour la prise en charge de l’infection par le virus de l’hépatite C chez les usagers de drogues par injectionInternational Journal of Drug Policy 2015; : 101669 doi: 10.1016/j.drugpo.2015.11.009
58
Qi Wu, Zhubing Li, Qiang Liu. An important role of SREBP-1 in HBV and HCV co-replication inhibition by PTENVirology 2018; 520: 94 doi: 10.1016/j.virol.2018.05.011
59
Regiane M. A. Sampaio, Paola Eduarda F. Dantas, Maria Inês C. da Silva, Joseane R. da Silva, Patrícia F. Nunes, Amanda C. Gomes, Luisa C. Martins. Comparison of Patients Monoinfected with Hepatitis C Virus and Coinfected with Hepatitis B/C in the Amazon Region of BrazilViruses 2022; 14(5): 856 doi: 10.3390/v14050856
60
Derya Bayırlı Turan, Tuba Kuruoğlu, Defne Gümüş, Fatma Kalaycı, Kıvanç Şerefhanoğlu. Üçüncü basamak bir hastaneye başvuran hastalarda HBsAg ve anti-HCV seroprevalansı: Altı yıllık retrospektif verilerEge Tıp Dergisi 2019; : 149 doi: 10.19161/etd.502958
61
Zeinab Nabil Ahmed Said, Manal Hamdy El-Sayed. Challenge of managing hepatitis B virus and hepatitis C virus infections in resource-limited settingsWorld Journal of Hepatology 2022; 14(7): 1333-1343 doi: 10.4254/wjh.v14.i7.1333
62
V. Calvaruso, D. Ferraro, A. Licata, M. G. Bavetta, S. Petta, F. Bronte, G. Colomba, A. Craxì, V. Di Marco. HBV reactivation in patients with HCV/HBV cirrhosis on treatment with direct-acting antiviralsJournal of Viral Hepatitis 2018; 25(1): 72 doi: 10.1111/jvh.12754
63
Bilal Toka, Aydın Şeref Köksal, Ramazan Dertli, Göktuğ Şirin, Sami Fidan, Yakup Ülger, Ferda Harmandar, Abdullah Emre Yıldırım, Ahmet Tarik Eminler, Mehmet Asil, Yusuf Kayar, Murat Bıyık, Sedef Kuran, Mustafa Ihsan Uslan, Sadettin Hülagü. Hepatitis B Reactivation in Patients Treated with Direct-Acting Antivirals for Hepatitis CDigestive Diseases 2022; 40(5): 635 doi: 10.1159/000521298
64
Nathália Alves Araujo Almeida, Vanessa Salete de Paula. Occult Hepatitis B virus (HBV) infection and challenges for hepatitis elimination: A literature reviewJournal of Applied Microbiology 2022; 132(3): 1616 doi: 10.1111/jam.15351
65
Giovanni Raimondo, Teresa Pollicino. Hepatitis B Virus in Human DiseasesMolecular and Translational Medicine 2016; : 277 doi: 10.1007/978-3-319-22330-8_13
66
Pietro Lampertico, Kosh Agarwal, Thomas Berg, Maria Buti, Harry L.A. Janssen, George Papatheodoridis, Fabien Zoulim, Frank Tacke. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infectionJournal of Hepatology 2017; 67(2): 370 doi: 10.1016/j.jhep.2017.03.021
67
Bo Wen, Jian Zhang, Wenpei Liu, Ping Tang, Ting Xie, Liyan Huang, Yabin Hu, Kun Jin, Ping Zhang, Ziyan Liu, Ling Niu, Xiaowang Qu. HBV coinfection with HCV alters circulating Tfh cell distribution and impairs HCV neutralizing antibody responses Journal of Viral Hepatitis 2019;  doi: 10.1111/jvh.13106
68
C.E. Burton, K.E. Doucette, C.A. Mabilangan, S.S. Plitt, B.E. Lee, J.K. Preiksaitis. Hepatitis B and C serologic profiles of Canadian organ donors and recipients: retrospective 10-year review at a single centerTransplant Infectious Disease 2016; 18(4): 520 doi: 10.1111/tid.12558
69
Marianna G. Mavilia, George Y. Wu. HBV-HCV Coinfection: Viral Interactions, Management, and Viral ReactivationJournal of Clinical and Translational Hepatology 2018; 6(3): 1 doi: 10.14218/JCTH.2018.00016